BR112020026629A2 - Composições farmacêuticas na forma liofilizada - Google Patents
Composições farmacêuticas na forma liofilizada Download PDFInfo
- Publication number
- BR112020026629A2 BR112020026629A2 BR112020026629-9A BR112020026629A BR112020026629A2 BR 112020026629 A2 BR112020026629 A2 BR 112020026629A2 BR 112020026629 A BR112020026629 A BR 112020026629A BR 112020026629 A2 BR112020026629 A2 BR 112020026629A2
- Authority
- BR
- Brazil
- Prior art keywords
- group
- weight
- lyophilized
- pharmaceutical composition
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18180177.0 | 2018-06-27 | ||
| EP18180177 | 2018-06-27 | ||
| PCT/EP2019/066875 WO2020002353A1 (en) | 2018-06-27 | 2019-06-25 | Pharmaceutical compositions in lyophilized form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112020026629A2 true BR112020026629A2 (pt) | 2021-03-23 |
Family
ID=62814888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112020026629-9A BR112020026629A2 (pt) | 2018-06-27 | 2019-06-25 | Composições farmacêuticas na forma liofilizada |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20210244664A1 (https=) |
| EP (1) | EP3813788A1 (https=) |
| JP (1) | JP7401471B2 (https=) |
| CN (1) | CN113038930A (https=) |
| AU (1) | AU2019295027B2 (https=) |
| BR (1) | BR112020026629A2 (https=) |
| CO (1) | CO2021000223A2 (https=) |
| EA (1) | EA202092893A1 (https=) |
| IL (1) | IL279760B2 (https=) |
| MX (1) | MX2020013831A (https=) |
| WO (1) | WO2020002353A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025204688A1 (ja) * | 2024-03-26 | 2025-10-02 | 株式会社ダイセル | リン脂質膜保護用液体組成物 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1986003938A1 (en) | 1985-01-11 | 1986-07-17 | The Regents Of The University Of California | Method for preserving liposomes |
| US4857319A (en) * | 1985-01-11 | 1989-08-15 | The Regents Of The University Of California | Method for preserving liposomes |
| US4963362A (en) | 1987-08-07 | 1990-10-16 | Regents Of The University Of Minnesota | Freeze-dried liposome mixture containing cyclosporin |
| AU657961B2 (en) | 1991-04-19 | 1995-03-30 | Nexstar Pharmaceuticals, Inc. | Pharmaceutical formulation and process |
| AU6047996A (en) | 1995-06-07 | 1996-12-30 | Nexstar Pharmaceuticals, Inc. | Liposomal cyclosporin formulations as agents for immunosuppr ession and multiple drug resistant indications |
| TW497974B (en) * | 1996-07-03 | 2002-08-11 | Res Dev Foundation | High dose liposomal aerosol formulations |
| US5958378A (en) | 1996-07-03 | 1999-09-28 | Research Development Foundation | High dose liposomal aerosol formulations containing cyclosporin A or budesonide |
| IT1289938B1 (it) | 1997-02-20 | 1998-10-19 | Angelini Ricerche Spa | Preparazione farmaceutica comprendente liposomi liofilizzati in cui e' incapsulato un principio attivo altamente insolubile in acqua e |
| EP1506032A1 (en) | 2002-05-20 | 2005-02-16 | Research Development Foundation | Aerosol drug inhibition of lung metastases |
| US20050244891A1 (en) * | 2003-11-26 | 2005-11-03 | Applera Corporation | Ligand-containing micelles and uses thereof |
| DE602005010424D1 (de) * | 2004-06-03 | 2008-11-27 | Bracco Research Sa | Liposomale anordnung für die therapeutische und/oder diagnostische anwendung |
| DE102006051512A1 (de) * | 2005-12-06 | 2007-06-14 | Pari GmbH Spezialisten für effektive Inhalation | Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin |
| CA2631243A1 (en) * | 2005-12-08 | 2007-06-14 | Wyeth | Liposomal compositions |
| EP1797895A1 (en) * | 2005-12-16 | 2007-06-20 | Pevion Biotech Ltd. | An adjuvant system comprising virosomes and liposomes |
| US20110070294A1 (en) * | 2009-09-23 | 2011-03-24 | Javeri Indu | Methods for the Administration of Drugs Using Liposomes |
| CN103533936B (zh) * | 2011-05-17 | 2016-01-13 | 三菱瓦斯化学株式会社 | 含有吡咯并喹啉醌和糖的脂质体 |
| EP3069711A1 (en) * | 2015-03-16 | 2016-09-21 | PARI Pharma GmbH | Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection |
-
2019
- 2019-06-25 EA EA202092893A patent/EA202092893A1/ru unknown
- 2019-06-25 BR BR112020026629-9A patent/BR112020026629A2/pt unknown
- 2019-06-25 WO PCT/EP2019/066875 patent/WO2020002353A1/en not_active Ceased
- 2019-06-25 IL IL279760A patent/IL279760B2/en unknown
- 2019-06-25 JP JP2020571767A patent/JP7401471B2/ja active Active
- 2019-06-25 CN CN201980043201.0A patent/CN113038930A/zh active Pending
- 2019-06-25 MX MX2020013831A patent/MX2020013831A/es unknown
- 2019-06-25 AU AU2019295027A patent/AU2019295027B2/en active Active
- 2019-06-25 EP EP19732066.6A patent/EP3813788A1/en active Pending
- 2019-06-25 US US17/251,223 patent/US20210244664A1/en not_active Abandoned
-
2021
- 2021-01-14 CO CONC2021/0000223A patent/CO2021000223A2/es unknown
-
2023
- 2023-05-16 US US18/317,940 patent/US20230301914A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20210244664A1 (en) | 2021-08-12 |
| CA3104445A1 (en) | 2020-01-02 |
| IL279760A (en) | 2021-03-01 |
| CN113038930A (zh) | 2021-06-25 |
| WO2020002353A1 (en) | 2020-01-02 |
| CO2021000223A2 (es) | 2021-01-18 |
| JP2021528450A (ja) | 2021-10-21 |
| EP3813788A1 (en) | 2021-05-05 |
| MX2020013831A (es) | 2021-03-25 |
| EA202092893A1 (ru) | 2021-04-19 |
| IL279760B2 (en) | 2025-10-01 |
| JP7401471B2 (ja) | 2023-12-19 |
| IL279760B1 (en) | 2025-06-01 |
| AU2019295027A1 (en) | 2020-12-24 |
| US20230301914A1 (en) | 2023-09-28 |
| AU2019295027B2 (en) | 2024-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2421209C2 (ru) | Фармацевтические композиции, содержащие циклоспорин | |
| KR970007187B1 (ko) | 개선된 암포테리신 b 리포좀 제조법 | |
| JP3245955B2 (ja) | リポソーム | |
| BR112020020564A2 (pt) | Formulações de ciclosporina para uso no tratamento da síndrome de bronquiolite obliterante (bos) | |
| BRPI0619565A2 (pt) | composições lipossÈmicas | |
| US20230301914A1 (en) | Pharmaceutical compositions in lyophilized form | |
| JP7526103B2 (ja) | 大環状免疫抑制剤を含む吸入用組成物 | |
| CN101181284A (zh) | 注射用伊曲康唑冻干组合物及制备方法 | |
| US20040175417A1 (en) | Amphotericin B liposome preparation | |
| CA3104445C (en) | Pharmaceutical compositions in lyophilized form | |
| JP7726884B2 (ja) | 吸入可能な免疫抑制活性成分を含む分散液の調製のためのプロセス | |
| CA3161686C (en) | Process for the preparation of dispersions comprising inhalable immunosuppressive active ingredients | |
| EA048772B1 (ru) | Фармацевтические композиции в лиофилизированной форме | |
| EA046086B1 (ru) | Способ получения дисперсий, содержащих ингаляционные иммуносупрессивные активные ингредиенты | |
| EA044593B1 (ru) | Ингаляционные композиции, содержащие макроциклические иммуносупрессанты |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |